Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson’s disease and progressive supranuclear palsy-Reference-Cited by-同舟云学术

Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson’s disease and progressive supranuclear palsy

Published:2021-07 Issue: Volume:757 Page:135975
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Takahashi Kenta^ORCID,Iwaoka Kazuhiro,Takahashi Kai,Suzuki Yoshio,Taguchi Keita,Yamahara Kanako,Maeda Tetsuya

Publisher

Elsevier BV

Subject

General Neuroscience

Reference33 articles.

1. Parkinson’s disease;Kalia;Lancet,2015

2. New diagnostics and therapeutics for progressive supranuclear palsy;Boxer;Lancet Neurol.,2018

3. Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: Possible metabolites of relevance to Parkinson’s disease;Shen;Chem. Res. Toxicol.,1996

4. Pathogenesis of Parkinson’s disease: oxidative stress, environmental impact factors and inflammatory processes;Yuan;Neurosci. Bull.,2007

5. Oxidized DJ-1 as a possible biomarker of Parkinson’s disease;Saito;J. Clin. Biochem. Nutr.,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of alogliptin on lipopolysaccharide-induced experimental Parkinson's disease: Unrevealing neurochemical and histopathological alterations in rodents.;European Journal of Pharmacology;2024-07

2. Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy;2023-07-27

3. Characterization of the redox status of cancer patients through the d-ROMs and BAP test and correlation of these parameters with blood variables;2023-02-01

4. Biomarkers of oxidative stress and reproductive complications;Advances in Clinical Chemistry;2023

5. Fluid redox biomarkers in neurological disease;Modulation of Oxidative Stress;2023